Corvus Pharma (CRVS) – PRNewswire
-
Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818
-
Angel Pharmaceuticals Announces IND Acceptance for Clinical Trial of ITK Inhibitor CPI-818 in China
Back to CRVS Stock Lookup